Abstract:SummaryEukaryotes are endowed with multiple specialized DNA polymerases, some (if not all) of which are believed to play important roles in the tolerance of base damage during DNA replication. Among these DNA polymerases, Rev1 protein (a deoxycytidyl transferase) from vertebrates interacts with several other specialized polymerases via a highly conserved C-terminal region. The present studies assessed whether these interactions are retained in more experimentally tractable model systems, including yeasts, flie… Show more
“…The final crystallization sample containing the quaternary complex of the Rev1 CTD, Rev3/7, and Pol RIR complex was prepared by passing the protein mixture of Rev3/7 with a slight molar excess amount of the Rev1 CTD-Pol RIR complex through a size exclusion column ( 15 N-labeled Rev1 CTD in the presence of equal molar ratios of both GB1-Pol RIR and Pol was also recorded to establish the formation of the quaternary Rev1 CTD-Rev3/ 7-Pol RIR complex.…”
Section: Methodsmentioning
confidence: 99%
“…Rev1 interaction is required for the protective role of Pol against benzo[a]pyrene in mammalian cells, and it promotes Pol -mediated suppression of spontaneous mutations in human cells (17,18). Although the interactions between the Rev1 CTD and the RIRs of Y-family polymerases , , and are only found in vertebrates (15), the Rev1 CTD-Pol interaction is evolutionarily conserved from yeast to humans, highlighting the essential role of the Rev1-Pol interaction in translesion synthesis. Consistent with this notion, the Rev1 CTD is required for effective DNA damage tolerance in mammalian cells, and mutations of the Rev1 CTD display a profound defect in translesion synthesis with significantly reduced damage-induced mutagenesis in yeast (11,19).…”
mentioning
confidence: 99%
“…The scaffolding function of Rev1 in vertebrates is critically dependent on its C-terminal domain of ϳ100 amino acids (11), which has been shown to bind insertion polymerases , , and through their Rev1-interacting region (RIR) (12)(13)(14)(15) and extension polymerase through its Rev7 subunit (12,13,16). Rev1 interaction is required for the protective role of Pol against benzo[a]pyrene in mammalian cells, and it promotes Pol -mediated suppression of spontaneous mutations in human cells (17,18).…”
Background: Translesion synthesis in mammalian cells is achieved by sequential actions of insertion and extension polymerases. Results: We determined the Rev1-Pol -Pol complex structure and verified the binding interface with in vivo studies. Conclusion: Mammalian insertion and extension polymerases could cooperate within a megatranslesion polymerase complex nucleated by Rev1. Significance: The Rev1-Pol interface is a target for developing novel cancer therapeutics.
“…The final crystallization sample containing the quaternary complex of the Rev1 CTD, Rev3/7, and Pol RIR complex was prepared by passing the protein mixture of Rev3/7 with a slight molar excess amount of the Rev1 CTD-Pol RIR complex through a size exclusion column ( 15 N-labeled Rev1 CTD in the presence of equal molar ratios of both GB1-Pol RIR and Pol was also recorded to establish the formation of the quaternary Rev1 CTD-Rev3/ 7-Pol RIR complex.…”
Section: Methodsmentioning
confidence: 99%
“…Rev1 interaction is required for the protective role of Pol against benzo[a]pyrene in mammalian cells, and it promotes Pol -mediated suppression of spontaneous mutations in human cells (17,18). Although the interactions between the Rev1 CTD and the RIRs of Y-family polymerases , , and are only found in vertebrates (15), the Rev1 CTD-Pol interaction is evolutionarily conserved from yeast to humans, highlighting the essential role of the Rev1-Pol interaction in translesion synthesis. Consistent with this notion, the Rev1 CTD is required for effective DNA damage tolerance in mammalian cells, and mutations of the Rev1 CTD display a profound defect in translesion synthesis with significantly reduced damage-induced mutagenesis in yeast (11,19).…”
mentioning
confidence: 99%
“…The scaffolding function of Rev1 in vertebrates is critically dependent on its C-terminal domain of ϳ100 amino acids (11), which has been shown to bind insertion polymerases , , and through their Rev1-interacting region (RIR) (12)(13)(14)(15) and extension polymerase through its Rev7 subunit (12,13,16). Rev1 interaction is required for the protective role of Pol against benzo[a]pyrene in mammalian cells, and it promotes Pol -mediated suppression of spontaneous mutations in human cells (17,18).…”
Background: Translesion synthesis in mammalian cells is achieved by sequential actions of insertion and extension polymerases. Results: We determined the Rev1-Pol -Pol complex structure and verified the binding interface with in vivo studies. Conclusion: Mammalian insertion and extension polymerases could cooperate within a megatranslesion polymerase complex nucleated by Rev1. Significance: The Rev1-Pol interface is a target for developing novel cancer therapeutics.
“…Mutants in the UBM2 of Rev1 also display decreased survival and mutagenesis in response to DNA damage that is likely caused by a less efficient interaction with monoubiquitinated PCNA (Guo et al 2006b;Wood et al 2007;D'Souza et al 2008;Bomar et al 2010). Additional studies found that the last $100 amino acids of Rev1 could interact with the other TLS polymerases in mammalian cells (Murakumo et al 2001;Guo et al 2003;Ohashi et al 2004;Tissier et al 2004) and in S. cerevisiae (Acharya et al 2005(Acharya et al , 2006D'Souza and Walker 2006;D'Souza et al 2008;Kosarek et al 2008). Not surprisingly, truncations of, or point mutations in, the C terminus cause severe survival and mutagenesis defects after DNA damage (Larimer et al 1989;Ross et al 2005;Acharya et al 2006;D'Souza et al 2008;Kosarek et al 2008).…”
mentioning
confidence: 99%
“…Additional studies found that the last $100 amino acids of Rev1 could interact with the other TLS polymerases in mammalian cells (Murakumo et al 2001;Guo et al 2003;Ohashi et al 2004;Tissier et al 2004) and in S. cerevisiae (Acharya et al 2005(Acharya et al , 2006D'Souza and Walker 2006;D'Souza et al 2008;Kosarek et al 2008). Not surprisingly, truncations of, or point mutations in, the C terminus cause severe survival and mutagenesis defects after DNA damage (Larimer et al 1989;Ross et al 2005;Acharya et al 2006;D'Souza et al 2008;Kosarek et al 2008). Given that these domains bind other proteins and contribute to survival and mutagenesis for a spectrum of DNA damage, it has been proposed that Rev1 acts a scaffolding protein that promotes the recruitment of TLS polymerases to sites of DNA adducts and/or aids in the recognition of DNA lesions (Waters et al 2009).…”
A cell's ability to tolerate DNA damage is directly connected to the human development of diseases and cancer. To better understand the processes underlying mutagenesis, we studied the cell's reliance on the potentially error-prone translesion synthesis (TLS), and an error-free, template-switching pathway in Saccharomyces cerevisiae. The primary proteins mediating S. cerevisiae TLS are three DNA polymerases (Pols): Rev1, Pol z (Rev3/7), and Pol h (Rad30), all with human homologs. Rev1's noncatalytic role in recruiting other DNA polymerases is known to be important for TLS. However, the biological significance of Rev1's unusual conserved DNA polymerase activity, which inserts dC, is much less well understood. Here, we demonstrate that inactivating Rev1's DNA polymerase function sensitizes cells to both chronic and acute exposure to 4-nitroquinoline-1-oxide (4-NQO) but not to UV or cisplatin. Full Rev1-dependent resistance to 4-NQO, however, also requires the additional Rev1 functions. When error-free tolerance is disrupted through deletion of MMS2, Rev1's catalytic activity is more vital for 4-NQO resistance, possibly explaining why the biological significance of Rev1's catalytic activity has been elusive. In the presence or absence of Mms2-dependent error-free tolerance, the catalytic dead strain of Rev1 exhibits a lower 4-NQO-induced mutation frequency than wild type. Furthermore, Pol z, but not Pol h, also contributes to 4-NQO resistance. These results show that Rev1's catalytic activity is important in vivo when the cell has to cope with specific DNA lesions, such as N 2 -dG.
In order to keep subscribers up‐to‐date with the latest developments in their field, this current awareness service is provided by John Wiley & Sons and contains newly‐published material on yeasts. Each bibliography is divided into 10 sections. 1 Reviews; 2 General; 3 Biochemistry; 4 Biotechnology; 5 Cell Biology; 6 Gene Expression; 7 Genetics; 8 Physiology; 9 Medical Mycology; 10 Recombinant DNA Technology. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted. (3 weeks journals ‐ search completed 30th. July 2008)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.